4-(9H-Carbazol-4-yloxy)-1-[2-(2-methoxyphenoxy)ethylamino]butan-2-ol

CAS : 955371-84-3

Ref. 3D-FNB37184

Informations sur le produit

• Nom: 4-(9H-Carbazol-4-yloxy)-1-[2-(2-methoxyphenoxy)ethylamino]butan-2-ol

Description

Carbidopa is a drug that is used to treat Parkinson's disease and high blood pressure. It is a racemic mixture of two enantiomers, (±)-N-Carbamoyl-4-(9H-carbazol-4-yloxy)-1-[2-(2-methoxyphenoxy)ethylamino]butan-2-ol. Carbidopa inhibits the breakdown of dopamine by inhibiting the enzyme DOPA decarboxylase, which converts dopamine into another neurotransmitter called noradrenaline. Carbidopa also reduces the production of L-type calcium currents in cardiac myocytes by binding to the ryanodine receptor and reducing sarcoplasmic Ca2+ overload in cardiac muscle cells. The drug has been shown to be effective against inflammatory diseases such as asthma and arthritis. When used to treat congestive heart failure, carbidopa has been shown to reduce the occurrence of ventricular arrhythmia due to

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 420.5 g/mol
• Formule: C₂₅H₂₈N₂O₄
• Degré de pureté: Min. 95%